KA
AMGN icon

Kovack Advisors’s Amgen AMGN Stock Holding History

Kovack Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1
Closed -$1K – 460
2018
Q4 		$1K Hold
1
– – ﹤0.01% 417
2018
Q3 		$1K Buy
+1
New +$197 ﹤0.01% 456

Other funds holding AMGN

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Kovack Advisors's AMGN Position: Q2 2026 in Review

Kovack Advisors reduced its Amgen (AMGN) stake by 8.6% in Q2 2026, selling an estimated $142K and leaving 4,406 shares worth $1.59M. The position accounts for 0.08% of the portfolio, ranked #259.

Kovack Advisors first reported a position in AMGN in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.7M in Q1 2026. 1,385 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kovack Advisors held 4,406 shares of Amgen worth $1.59M as of Q2 2026.
  • Kovack Advisors sold 415 Amgen shares in Q2 2026, an estimated $142K.
  • Amgen made up 0.08% of Kovack Advisors's portfolio in Q2 2026, its #259 holding.
  • Kovack Advisors first reported a position in Amgen in Q2 2015 and has held it in 44 quarters since.
  • Kovack Advisors's Amgen position peaked at $1.7M in Q1 2026.
  • 1,385 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.